Medrio offers solutions and support to pharmaceuticals, biotech, medical devices, and diagnostics, ensuring quality data capture and optimized workflows with CDMS/EDC, eCOA/ePRO, eConsent, and RTSM solutions.
N/A
Zelta
Score8 out of 10
N/A
Zelta is a cloud-based unified clinical data management and acquisition platform with customizable modules, that can be tailored to the meet the needs of clinical trials and accelerate outcomes.
N/A
Pricing
Medrio
Zelta
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Medrio
Zelta
Free Trial
No
No
Free/Freemium Version
No
No
Premium Consulting/Integration Services
No
Yes
Entry-level Setup Fee
No setup fee
Optional
Additional Details
—
Subscription - For larger organizations and those who need a predictable budget. Most modules included without incurring additional fees. Eligible for volume discounts.
Pay per use - For organizations that need flexibility without a long term contractual commitment. Transparent a la carte pricing, no minimums. Fees start when trial goes live.
More Pricing Information
Community Pulse
Medrio
Zelta
Considered Both Products
Medrio
No answer on this topic
Merative
Verified User
Chose Zelta
Zelta by Merative supersedes the MedrioEDC at any given point of time and on all evaluation criteria. Also as compared to Medidata Rave EDC, database programming is easier due to its intuitive GUI; someone with little or absolutely no knowledge of any programming language can …
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Verified User
Chose Zelta
Zelta by Merative supersedes the MedrioEDC at any given point of time and on all evaluation criteria. Also as compared to Medidata Rave EDC, database programming is easier due to its intuitive GUI and someone with little or absolutely no knowledge of any programming language …
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Manager Data Management at Biorasi (Pharmaceuticals, 51-200 employees)
Chose Zelta
Zelta has an easier set-up, maintenance and modifiability. Also, there is a cost saving when using Zelta by Merative for a study as Medidata is very expensive.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Verified User
Chose Zelta
More flexibility with Zelta, less heavy to design and offer[s] strong feature[s]. Rave is a stronger EDC system with a very interesting reporting option and a very good reputation with the users, however very heavy to manipulate from the design side.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Medrio is very user friendly and even allows the user to print out the eCRFs to be used as source documents. This makes creating source documents very easy for the Research team and the information directly matches the EDC, which makes the monitoring process go much smoother. The process for withdrawing a subject can be a bit confusing, as the system only allows for a "screen-failure" designation and not an option for withdrawal, or is lost to follow-up.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Zelta is a good tool for companies currently utilizing multiple software platforms to create and monitor clinical trial information. Due to the price, it is best suited for large pharmaceutical manufacturers with active pipelines and high R&D spend. Zelta's value is more limited to smaller, more focused companies.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
The system does not allow a separate designation for screen failures that were lost to follow-up or who were withdrawn by the PI.
When a subject is deemed a screen-failure, eCRFs are still expected to be filled out and it is unclear which ones unless otherwise directed by the in-house team.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
We cannot have multiple study accesses for a study in the studies supported by Zelta. eg. Coder and Data manager.
Though all the study-build related errors are flagged on the study-build page, some errors like incorrect dynamics applied, which eventually affects the subject PDF extraction, reports, etc.
When the study is imported from another Zelta studies, certain attributes remain running in the background even if it seems to be disabled.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
We are satisfied from our experience with Zelta by Merative, the close collaboration we have with the Zelta team is also something we value. We plan to use Zelta for a long time
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Zelta has many different functionalities as well as modules that can be used depending on what the sponsor wants. I like that they are optional so that when building a study, you can give the sponsor options if they want them or not. Many of the optional models I like to use (Training Tracking for example) as they make tracking Site training so much easier than sending training forms out.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
I have not had any technical issues with this product in the two years I've used it, which speaks for itself. I like how I am now able to use my email address to sign in instead of remembering yet another user name, this makes using this EDC a much more enjoyable experience.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Our organization has been using both Zelta and in-house applications. The main considerations on which one to use for a particular study is time to get the databases running, cost, and ease of use. For some studies, the time and cost of using Zelta are negative factors, and an in-house system is selected.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
It was easier to understand the usability of the software [Zelta]. For our engineers [it] was easier to migrate our data, and fully set up everything. We found out that comparing other software[s], this one is safe, easy to use, has more functionalities, [and it's] easier to work with team members everywhere making clinical trials more efficient.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
